Lung Volume Reduction in Emphysema: Valve, Coil and Vapor Methods
Lung volume reduction aims to make an overinflated area of the lung smaller in selected people with advanced emphysema. [1] The valve, coil and vapor methods are done with a bronchoscope, and their level of evidence and their risks differ. [1][2][3][5] If you have sudden chest pain or marked shortness of breath, call 112 (or your local emergency number) right away. [10][11][14]
This guide is for adults with advanced emphysema and their families. The guide gives general information. It does not give personal instructions. You make the treatment decision together with your doctor. Air trapped under the skin (subcutaneous emphysema) and emphysema in dentistry are not the topic of this guide.
What is emphysema, and what happens in the lung?
In emphysema, the walls of the air sacs of the lung are damaged. The lung can lose its elasticity and have trouble emptying air. [10]
When you breathe out, air can stay inside. This is called air trapping. The lung becomes overinflated, and the chest can become too full. The medical name for this is hyperinflation. [10]
The level of the disease and of air trapping differs from person to person. [10] Your doctor finds out your level with tests.
Is there a treatment for emphysema, and when is volume reduction considered?
Volume reduction is considered after standard treatment and rehabilitation have been given. [1] According to the GOLD report, these procedures can be considered as an option for a patient who has marked hyperinflation despite optimized treatment. [1] Your doctor assesses where you are in your treatment.
Volume reduction methods do not aim to remove emphysema, and they do not return the lung to normal. In selected patients they aim to make the overinflated area smaller. [1]
This guide does not explain drug treatment in detail. Talk about your medicine and rehabilitation plan with your chest physician.
What is lung volume reduction, and is it surgery?
Lung volume reduction is the general name for procedures that aim to make a selected, overinflated area of the lung smaller. [1][5] There are methods done with a bronchoscope and a surgical method. [1] In bronchoscopic methods, the chest is not opened.
The doctor passes a thin tube (a bronchoscope) through your mouth or nose. The valve, coil and vapor methods are done this way. [5][10][12]
In surgical volume reduction, part of the lung tissue is removed by an operation. [1] A bronchoscopic method does not mean no risk, and it does not mean no hospital stay. The risks are explained in the next sections.
In Türkiye, the terms "bronş içi valf" (endobronchial valve), "endobronşiyal valf", "sarmal tel" (coiled wire), "koil" and "akciğer hacim küçültme" (lung volume reduction) are used. [12][13] "Hacim küçültme" can describe both the bronchoscopic and the surgical method. On its own it does not name the method. [12][13]
Who may be a candidate for volume reduction?
These methods do not suit every person with advanced emphysema. The specialist team decides on suitability. [1] No single test decides candidacy. The team assesses your chest computed tomography (CT) scan, your breathing and exercise tests, your general health and the features of the target area together. [1][8]
The assessment looks at the following:
- How the emphysema is spread on the CT. [1]
- Air exchange between the target area and the neighboring lobes. [1]
- Your own preference. [1]
- Lung function and the level of hyperinflation. [8]
- Exercise capacity and other conditions you have. [8]
An active infection or another serious heart or lung problem can change suitability. These are assessed by method and by person. [5][10] There is no single common list of exclusions for the three methods.
Do I need to have quit smoking?
Quitting smoking is an important part of COPD (chronic obstructive pulmonary disease) care. [1] The criteria of centers may differ. GOLD does not give a fixed smoke-free period for all methods. [1] Before a procedure, talk with your treatment team about your smoking and how long ago you quit.
The patient document of the Turkish Thoracic Society lists at least six months without smoking in the assessment of a candidate. [13]
If you smoke, ask your doctor for help to quit. Do not decide on your own that "this many months is enough."
Which tests are done before the procedure?
Your doctor may order different tests to assess your lung function, exercise capacity, CT findings and heart and lung condition. [1][8] The tests needed vary by person. Not everyone has all the tests.
An expert panel includes these tests in the first assessment: a cardiopulmonary exercise test, a high-resolution CT, a perfusion scan and an echocardiogram. [8] A hospital document lists blood tests, a heart electrocardiogram (ECG), chest imaging and breathing tests. [10]
The test list of one hospital is not the protocol of every center in Türkiye. Ask your team about the plan of your own center.
Medicines and fasting. Tell the team about all the medicines you take, including blood thinners. Do not stop any medicine on your own decision. [10] Your hospital tells you when to stop eating and drinking. Follow the times you are given. [10]
Consent. Before the procedure you talk with the team about the benefits, the risks and the options. Also ask what happens if the procedure is not done. Then you give your consent for the procedure. [6][10]
How does the valve method work, and who is it suitable for?
The valve method is based on a one-way valve that is placed in the airway with a bronchoscope. The valve limits new air going into the target area. It lets the air inside get out. [10]
For the valve to work, there must be very little air flow between the target lobe and the neighboring lobe. [1][2] The line between lobes is called the fissure. The CT is used to examine whether the fissure is intact. In patients who need it, air flow is measured with a balloon during bronchoscopy. This is called the collateral ventilation test. [1]
If the fissure is not complete, the valve may not be suitable. This decision is again the team's. [1] The fissure requirement is asked for the valve. GOLD does not ask for the same requirement for the coil and vapor methods. [1]
What is the coil (coiled wire) method?
In the coil method, wires are placed in the target airways with a bronchoscope. When the wires are released, they take a coiled shape. The aim is to reduce the volume of the overinflated area. [12][13]
The current production and availability of coil devices may vary by model. A 2025 German registry publication reports that the manufacturer of one coil model stopped production. [21] Current availability in Türkiye could not be verified with these sources. Ask your center.
How is the vapor method done?
In the vapor method, hot water vapor is delivered to the target segment with a bronchoscope. The volume reduction develops over time. [5] The evidence for the method is explained together with the valve and the coil in the section "What is the evidence for the valve, coil and vapor methods?" [1][5]
In this method, a catheter is advanced through the bronchoscope to the target segment. A balloon closes the area for a short time. The planned dose of hot water vapor is delivered through the catheter. The response of the tissue can lead to volume reduction over time. [5]
The volume reduction does not develop at once. NICE reports that the reduction typically develops within 4-6 weeks. Breathing symptoms can increase in the first 2-4 weeks. [5]
One of the main studies for the vapor method is STEP-UP. The study included patients with upper-lobe-predominant, heterogeneous emphysema. Fissure status was not a selection criterion. [3] A later subgroup analysis in patients with incomplete fissures reported promising findings. This analysis is not a separate randomized study. It does not show the result in advance for every patient. [4]
NICE states that this procedure is not done if there is evidence of an active lung infection. [5]
You can find technical information about the method on this page: Technical information about the vapor method
What is the evidence for the valve, coil and vapor methods?
The evidence for the three methods is not the same. GOLD describes the valve as the best studied of the bronchoscopic methods. [1] For the coil and vapor methods, GOLD states that clinical access is limited. [1] The team decides which one can be considered, using the CT and other tests. [1]
- Valve. A one-way valve that limits air going in. [10] The integrity of the fissure and collateral ventilation are important. [1] GOLD reports that in selected patients without collateral ventilation, randomized studies showed increases in FEV1, walking distance and health status at 6 and 12 months. [1] The evidence rests on randomized studies such as LIBERATE, TRANSFORM and EMPROVE. [2][15][16] The sources of this guide do not include a NICE assessment for the valve.
- Coil. Wires that take a coiled shape in the target airway. [12][13] A fissure requirement is not asked for. [1] In coil studies, GOLD reports an increase in walking distance and smaller improvements in FEV1 and quality of life. Major complications were more common in the coil group. [1] The evidence rests on the randomized studies RENEW and REVOLENS. [19][20] NICE finds the evidence for the coil limited in quantity and quality, and recommends that the method be used only in a research setting. [22]
- Vapor. Controlled hot water vapor delivered to the target segment with a catheter. [5] A fissure requirement is not asked for. [1] GOLD counts the method among the options in selected patients. It reports an improvement in lung function and health status at month 6 in one randomized study. [1] NICE finds the evidence of safety and efficacy inadequate in quantity and quality, and recommends that the method be done in a research setting. [5] The main randomized study is STEP-UP. [3] GOLD and NICE do not assess this method in the same way.
The level of evidence does not show that a method will work for you.
No source in the basis of this guide compares these methods directly and shows that one is better. The studies were done in different patient groups, with different outcome measures and over different periods. Do not compare study rates directly between methods. [1][2][3]
How is the procedure done, will I be asleep, and how many days do I stay in the hospital?
The procedure is mostly done under anesthesia. One hospital document reports an average stay of about three days after a valve. [10] The team decides which anesthesia method will be used, according to your condition. [5][10][12] The vapor method is usually done under general anesthesia. [5] The valve information document states that the patient is put to sleep during the procedure. [10]
Because of the anesthesia, you may be asleep during the procedure. Afterward you may have a sore throat or a cough. [10] There is not enough evidence to say "it is painless."
The length of the procedure depends on the method, the number of target areas and your condition. A single duration that can be given to patients for the three methods is not in the sources of this guide. Ask your team how long the procedure will take and how long you will stay in the hospital.
After a valve, monitoring in the hospital may be needed. The stay can be shorter or longer. [10] Most pneumothoraces after a valve are seen in the first 72 hours. [1] The length of stay varies by center, by your recovery and by whether there is a complication.
A single common time for return to daily life is not in the sources of this guide. Ask the discharge team when you can return to activity and what you should limit. [5][10]
How much benefit can I get from volume reduction?
In selected patients, bronchoscopic volume reduction can improve lung function, exercise tolerance and health status over 6-12 months. [1] The benefit may not be the same in everyone. [1]
Benefit is followed with measures of shortness of breath, quality of life, exercise capacity and lung function. [1][3] There is no single "day the result appears." Your team decides the follow-up times and measurements. [1]
The 6- and 12-month measurement points in the studies do not mean that your personal result will be settled by that date. [1][3]
The numbers below belong to selected patient groups in the studies. They are not a prediction of your personal benefit. FEV1 is the amount of air you breathe out in the first second. SGRQ is a quality-of-life questionnaire; a lower score means improvement.
Valve.
- In LIBERATE at month 12, compared with the control group, the FEV1 difference was +0.106 liters, the 6-minute walking distance difference was +39.31 meters, and the SGRQ difference was -7.05 points. [2]
- In LIBERATE, the share of patients whose FEV1 rose by at least 15 percent was 47.7 percent in the valve group and 16.8 percent in the control group. [2]
- In TRANSFORM at month 6, FEV1 responders were 56.3 percent against 3.2 percent. The 6-minute walking distance difference was +78.7 meters. [15]
- In EMPROVE, the FEV1 difference was +0.101 liters at month 6 and +0.099 liters at month 12. [16]
- In the EMPROVE follow-up, some benefits in selected patients lasted up to month 24. [18] This period does not apply to every patient.
Coil.
- In RENEW at month 12, the median difference in 6-minute walking distance was +14.6 meters, the adjusted median increase in FEV1 was 7 percent, and the SGRQ difference was -8.9 points. [19] The clinical importance of the walking difference was assessed as uncertain. [19]
- In REVOLENS, the FEV1 difference was +0.09 liters at month 6 and +0.08 liters at month 12. The SGRQ difference was -13.4 and -10.6 points, respectively. [20]
- In REVOLENS, the walking distance difference was +21 meters at both time points, and it was not found statistically significant. [20]
Vapor.
- In STEP-UP at month 6, FEV1 improved by 14.7 percent in relative terms in the treatment group. The SGRQ-C quality-of-life score fell by 9.7 points. [3] The study was small and open-label.
- GOLD reports that in selected patients, improvement can be achieved over 6-12 months with bronchoscopic methods in general. [1] Ask your team about the expected benefit.
What are the risks of volume reduction?
One of the most important risks is pneumothorax. Pneumothorax is air leaking between the lung and the chest wall. In everyday speech it is called a collapsed lung. It can occur after a valve and after a coil, and it was also investigated in the vapor study. [2][3][19]
Valve.
- Pneumothorax: In LIBERATE, within 45 days after the procedure, it occurred in 34 of 128 patients (26.6 percent). [2] In TRANSFORM, it occurred in 19 of 65 patients (29.2 percent) in the valve group. [15] In EMPROVE, serious pneumothorax was reported as 12.4 percent. [16] The rates vary by study and by patient group.
- Consequences of pneumothorax: Among the unwanted effects of valve treatment are pneumothorax, removal of the valve and replacement of the valve. [1] Of the pneumothoraces, 76 percent were seen in the first 72 hours after the procedure. [1]
- Exacerbations and serious events: In EMPROVE, serious chest-related adverse events up to 6 months were 31.0 percent in the valve group and 11.9 percent in the control group. [16] GOLD reports that after the post-procedure period, exacerbations were seen less often in the valve group than in the control group. [1]
- Death: In LIBERATE, 4 patients in the valve group died in the first 45 days. From the following period to month 12, one death each was reported in the valve and control groups. [2] In BeLieVeR-HIFi, two deaths were reported in the valve group. The abstract of the publication does not state the cause of the deaths. [17] A single death rate does not show a personal risk.
- Common and usually mild symptoms: Sore throat, cough, hoarseness, mild fever, bloody sputum or a low oxygen level can occur. [10] If the symptoms continue or get worse, tell your team.
Coil.
- Major complication: In RENEW, at least one major complication occurred in 34.8 percent of the coil group and 19.1 percent of the control group. [19]
- Pneumothorax and pneumonia: In RENEW at 12 months, pneumothorax was 9.7 percent in the coil group and 0.6 percent in the control group. Pneumonia was 20 percent against 4.5 percent. [19]
- Exacerbations and other events: GOLD reports that pneumonia, pneumothorax, hemoptysis (coughing up blood) and COPD exacerbation were more common in the coil group. [1]
- Death: In REVOLENS at 12 months, 4 patients in the coil group and 3 in the control group died. [20]
- Removal and repeat procedure: A comparable rate for coil removal or repeat procedure could not be verified in these sources.
Vapor.
- Exacerbation: COPD exacerbation was the most common serious adverse event in the vapor study STEP-UP. It occurred in 11 of 45 people (24 percent) in the treatment group and in 1 of 24 people (4 percent) in the control group. [3][7]
- Death: In STEP-UP, one patient died 84 days after treatment because of complications of an exacerbation. The monitoring board assessed the event as possibly related to the treatment. [3][7]
- Infection and inflammation: In STEP-UP, pneumonia or pneumonitis (inflammation of the lung) was seen within 6 months. It was reported in 8 of 45 people (18 percent) in the treatment group and in 2 of 24 people (8 percent) in the control group. [7]
- Pneumothorax: In the STEP-UP abstract, no pneumothorax was reported in the 30 days after treatment. [3] The study is small. This finding does not show that the vapor method has no risk of pneumothorax.
The studies differ in the number of patients, the selection criteria and the length of follow-up. STEP-UP is a small study. There were 45 patients in the treatment group and 24 in the control group. The study was open-label; the patient and the doctor knew who was in which group. [3] No study rate is an estimate of your own risk. Do not compare the rates directly between methods. Ask your team about all the risks of the method.
Which symptoms mean I should go to the hospital right away or call 112?
If you have sudden chest pain or marked shortness of breath after the procedure, do not wait. Call 112 (or your local emergency number) right away, or go to the nearest emergency department. [10][11][14]
WARNING: If any of the following happens after the procedure, call 112 (or your local emergency number) right away.
- Chest pain that starts suddenly. [10][11]
- Shortness of breath that starts suddenly or is marked. [10][11]
- Fainting or a life-threatening situation.
In these cases, contact your procedure team right away. High fever, a cough that gets worse, or bloody sputum. [10][11]
Not all of these symptoms are specific to pneumothorax. Only a doctor makes the diagnosis. The emergency instruction in your discharge document comes first. Do not wait at home thinking the symptom is "normal."
How does it relate to surgical lung volume reduction?
Bronchoscopic methods and surgery are different options that can be considered in suitable patients. The choice is made with the team's assessment. [1] One does not replace the other.
Surgical volume reduction also aims to make the overinflated area of the lung smaller. In surgery, part of the lung tissue is removed by an operation. [1] The randomized study of the surgical method, which compared it with medical treatment, is NETT. [9]
This guide's sources do not show that bronchoscopic methods or surgery are directly better than each other. Talk with your chest medicine and thoracic surgery team about which path suits you.
What should I look for when I talk with a center?
Ask the team questions. Make the decision together. [6][10] Not every method is done at every center. Ask which methods are done at your center and by which criteria.
The section "Questions you can ask your doctor" below helps you prepare for this talk.
Questions you can ask your nurse
- What is my level of air trapping (hyperinflation)? Is volume reduction an option for me?
- Which tests do I need to have? When are these tests done?
- Can the fissure and collateral ventilation assessment for the valve be done in my case? What does the result say?
- Which method is being considered for me, and why? Why are the other methods not suitable?
- What is your center's criterion on my quitting smoking? Can I get support to quit?
- How will I adjust which of my medicines before the procedure? I take blood thinners.
- What are the benefits and risks of the suggested method in my case? What is done if a pneumothorax or an exacerbation happens?
- How will the procedure be done, what type of anesthesia is used, and how many days will I stay in the hospital?
- After the procedure, by which symptoms should I call you? Whom will I reach at night and on weekends?
- Can surgical volume reduction be discussed for me? Which methods are done at this center?
Frequently asked questions
What is emphysema?
In emphysema, the walls of the air sacs of the lung are damaged. The lung can lose its elasticity and have trouble emptying air. [10] This can lead to air trapping and to too much fullness in the chest. [10]
Is there a treatment for emphysema?
Volume reduction methods do not aim to remove emphysema. In selected patients they aim to make the overinflated area smaller. [1] Standard treatment and rehabilitation come first. [1] Your doctor decides which treatment is suitable.
What is lung volume reduction?
They are bronchoscopic or surgical methods that aim to make the overinflated part of the lung smaller in selected patients. [1] The bronchoscopic method and surgery are not the same procedure. [1][12]
What is valve treatment for emphysema, and how does it work?
The valve method is based on a one-way valve that is placed in the airway with a bronchoscope. The valve limits air going into the target area and lets the air inside get out. [10]
Can a valve be placed if the fissure is not complete?
The integrity of the fissure and collateral ventilation are important for the success of the valve. [1][2] If the fissure is not complete, the valve may not be suitable. The team decides. [1] This requirement is not asked for in the same way for the coil and vapor methods. [1]
What is coil or coiled wire treatment?
Wires that take a coiled shape are placed in the target area with a bronchoscope. The aim is to reduce the volume of the overinflated area. [12][13] There are randomized studies for the coil. [19][20]
How is vapor treatment for emphysema done, and what is the evidence?
Hot water vapor is delivered in a planned dose to the target segment with a catheter through the bronchoscope. [5] NICE finds the evidence limited and recommends that it be done in a research setting. [5] GOLD, on the other hand, counts it as an option in selected patients. [1] For the coil too, NICE finds the evidence limited and recommends only a research setting. [22]
What are the risks of coil treatment?
In the RENEW study at 12 months, pneumothorax was 9.7 percent in the coil group and 0.6 percent in the control group. Pneumonia was 20 percent against 4.5 percent. [19] These rates belong to that study and do not show a personal risk. [19]
What are the risks of vapor treatment?
In the STEP-UP study, COPD exacerbation occurred in 11 of 45 people in the treatment group and 1 of 24 people in the control group. Pneumonia or pneumonitis was reported in 8 against 2 people. One patient died 84 days after treatment. [3][7] The study is small, and the rates do not show a personal risk. [3]
Can a person who smokes be a candidate?
Quitting smoking is important in COPD care. [1] A patient document lists at least six months without smoking. [13] The sources of this guide do not give a common fixed period for all methods. Ask for the criterion of your center. [1]
Should I stop my medicines before the procedure?
No, do not stop them on your own decision. Tell the team about all medicines, including blood thinners. Your doctor makes the adjustment. [10]
Will I be asleep during the procedure?
The procedure is mostly done under anesthesia. The team decides which anesthesia method is used, according to your condition. [5][10][12]
Can the lung collapse after a valve, can a pneumothorax happen?
Yes, it can. In the LIBERATE study, pneumothorax occurred in 34 of 128 patients (26.6 percent) within 45 days after a valve. [2] This is why monitoring is needed. [1][10] If you have sudden chest pain or marked shortness of breath, call 112 (or your local emergency number) right away. [10][11][14]
About this guide
Melekırmak prepared this guide. It is based on guidelines and patient information documents. It does not replace the advice of your doctor. Melekırmak is the distributor in Türkiye of some of the medical devices used in the procedures described in this guide.
Published:
Last updated:
Sources
- 1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD, 2025 Report. 2025.
- 2. Criner GJ, et al. A Multicenter Randomized Controlled Trial of Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE). Am J Respir Crit Care Med, 2018.
- 3. Herth FJ, et al. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: STEP-UP trial. Lancet Respir Med, 2016.
- 4. Gompelmann D, et al. Lung Volume Reduction with Vapor Ablation in the Presence of Incomplete Fissures: 12-Month Results from STEP-UP. Respiration, 2016.
- 5. NICE. Bronchoscopic thermal vapour ablation for upper-lobe emphysema, IPG652. National Institute for Health and Care Excellence, 2019.
- 6. NICE. IPG652 patient information: Bronchoscopic thermal vapour ablation for upper-lobe emphysema. 2019.
- 7. NICE. Interventional procedures overview: Bronchoscopic thermal vapour ablation for upper-lobe emphysema. 2019.
- 8. Herth FJF, Slebos DJ, Criner GJ, Valipour A, Sciurba F, Shah PL. Endoscopic Lung Volume Reduction: An Expert Panel Recommendation, Update 2019. Respiration, 2019.
- 9. Fishman A, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema (NETT). N Engl J Med, 2003.
- 10. University Hospitals Coventry and Warwickshire NHS Trust. Endobronchial Valve procedure for treatment of Emphysema, patient information. Updated 2025.
- 11. University of Michigan Health. Preparing for Your Endobronchial Valve Placement. 2024.
- 12. Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital. Endobronchial valve and coiled wire (coil) treatment in COPD (in Turkish). 2025.
- 13. Turkish Thoracic Society. Lung volume reduction methods in chronic obstructive pulmonary disease (valve, coiled wire) (in Turkish). The date of the document could not be verified on the page.
- 14. Republic of Türkiye Ministry of the Interior. 112 Emergency Call Center (in Turkish). Accessed 2026.
- 15. Kemp SV, et al. A Multicenter Randomized Controlled Trial of Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM). Am J Respir Crit Care Med, 2017.
- 16. Criner GJ, et al. A Multicenter Randomized Controlled Trial of Endobronchial Valve Treatment in Heterogeneous Emphysema (EMPROVE). Am J Respir Crit Care Med, 2019.
- 17. Davey C, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (BeLieVeR-HIFi). Lancet, 2015.
- 18. EMPROVE 24-month follow-up study. Annals of the American Thoracic Society, 2024.
- 19. Sciurba FC, et al. Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema (RENEW). JAMA, 2016.
- 20. Deslée G, et al. Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema (REVOLENS). JAMA, 2016.
- 21. German Emphysema Registry, results of endobronchial coil use (German registry publication), 2025.
- 22. NICE. Insertion of endobronchial nitinol coils to improve lung function in emphysema, IPG517 (now named HTG370). 2015.